248 related articles for article (PubMed ID: 30125928)
1. Impact of sialendoscopy on improving health related quality of life in patients suffering from radioiodineinduced xerostomia.
Bulut OC; Haufe S; Hohenberger R; Hein M; Kratochwil C; Rathke H; Plinkert PK; Baumann I; Holland-Letz T; Haberkorn U; Flechsig P
Nuklearmedizin; 2018 Aug; 57(4):160-167. PubMed ID: 30125928
[TBL] [Abstract][Full Text] [Related]
2. Initial clinical experience performing sialendoscopy for salivary gland protection in patients undergoing
Rathke H; Kratochwil C; Hohenberger R; Giesel FL; Bruchertseifer F; Flechsig P; Morgenstern A; Hein M; Plinkert P; Haberkorn U; Bulut OC
Eur J Nucl Med Mol Imaging; 2019 Jan; 46(1):139-147. PubMed ID: 30151743
[TBL] [Abstract][Full Text] [Related]
3. Sialendoscopy for Patients with Radioiodine-Induced Sialadenitis and Xerostomia.
Bhayani MK; Acharya V; Kongkiatkamon S; Farah S; Roberts DB; Sterba J; Chambers MS; Lai SY
Thyroid; 2015 Jul; 25(7):834-8. PubMed ID: 25860842
[TBL] [Abstract][Full Text] [Related]
4. Interventional sialendoscopy for treatment of radioiodine-induced sialadenitis.
Bomeli SR; Schaitkin B; Carrau RL; Walvekar RR
Laryngoscope; 2009 May; 119(5):864-7. PubMed ID: 19266587
[TBL] [Abstract][Full Text] [Related]
5. Salivary gland function after sialendoscopy for treatment of chronic radioiodine-induced sialadenitis.
Kim YM; Choi JS; Hong SB; Hyun IY; Lim JY
Head Neck; 2016 Jan; 38(1):51-8. PubMed ID: 24995941
[TBL] [Abstract][Full Text] [Related]
6. Salivary gland function 5 years after radioactive iodine ablation in patients with differentiated thyroid cancer: direct comparison of pre- and postablation scintigraphies and their relation to xerostomia symptoms.
Jeong SY; Kim HW; Lee SW; Ahn BC; Lee J
Thyroid; 2013 May; 23(5):609-16. PubMed ID: 23153322
[TBL] [Abstract][Full Text] [Related]
7. Interventional sialendoscopy for radioiodine-induced sialadenitis: quo vadis?
Canzi P; Cacciola S; Capaccio P; Pagella F; Occhini A; Pignataro L; Benazzo M
Acta Otorhinolaryngol Ital; 2017 Apr; 37(2):155-159. PubMed ID: 28516979
[TBL] [Abstract][Full Text] [Related]
8. Sialendoscopy-assisted treatment for radioiodine-induced sialadenitis.
Wu CB; Xi H; Zhou Q; Zhang LM
J Oral Maxillofac Surg; 2015 Mar; 73(3):475-81. PubMed ID: 25544300
[TBL] [Abstract][Full Text] [Related]
9. Sialendoscopy in the Management of Radioiodine Induced Sialadenitis: A Systematic Review.
Cung TD; Lai W; Svider PF; Hanba C; Samantray J; Folbe AJ; Shkoukani M; Raza SN
Ann Otol Rhinol Laryngol; 2017 Nov; 126(11):768-773. PubMed ID: 28949251
[TBL] [Abstract][Full Text] [Related]
10. Radioprotection of salivary glands by amifostine in high-dose radioiodine treatment. Results of a double-blinded, placebo-controlled study in patients with differentiated thyroid cancer.
Bohuslavizki KH; Klutmann S; Brenner W; Kröger S; Buchert R; Bleckmann C; Mester J; Henze E; Clausen M
Strahlenther Onkol; 1999 Nov; 175 Suppl 4():6-12. PubMed ID: 10584133
[TBL] [Abstract][Full Text] [Related]
11. Scintigraphic evaluation of salivary gland dysfunction in patients with thyroid cancer after radioiodine treatment.
Caglar M; Tuncel M; Alpar R
Clin Nucl Med; 2002 Nov; 27(11):767-71. PubMed ID: 12394122
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic sialendoscopy for the management of radioiodine sialadenitis.
Prendes BL; Orloff LA; Eisele DW
Arch Otolaryngol Head Neck Surg; 2012 Jan; 138(1):15-9. PubMed ID: 22249623
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors of
Hollingsworth B; Senter L; Zhang X; Brock GN; Jarjour W; Nagy R; Brock P; Coombes KR; Kloos RT; Ringel MD; Sipos J; Lattimer I; Carrau R; Jhiang SM
J Clin Endocrinol Metab; 2016 Nov; 101(11):4085-4093. PubMed ID: 27533304
[TBL] [Abstract][Full Text] [Related]
14. Preserving formerly impaired salivary gland function in radioiodine-treated thyroid papillary carcinoma.
Aframian DJ; Nahlieli O; Knopf A; Lukach L; Qawasmeh N; Nadler C
Quintessence Int; 2013 May; 44(5):439-44. PubMed ID: 23479590
[TBL] [Abstract][Full Text] [Related]
15. [Salivary gland damage after 131I therapy in patients with differentiated thyroid cancer. Preliminary report].
Macioszek A; Baczyk M; Kopeć T; Sowiński J
Endokrynol Pol; 2008; 59(5):403-10. PubMed ID: 18979451
[TBL] [Abstract][Full Text] [Related]
16. Combined interventional sialendoscopy and intraductal steroid therapy for recurrent sialadenitis in Sjögren's syndrome: Results of a pilot monocentric trial.
Capaccio P; Canzi P; Torretta S; Rossi V; Benazzo M; Bossi A; Vitali C; Cavagna L; Pignataro L
Clin Otolaryngol; 2018 Feb; 43(1):96-102. PubMed ID: 28585263
[TBL] [Abstract][Full Text] [Related]
17. Sialendoscopy-assisted surgery and the chronic obstructive sialadenitis symptoms questionnaire: A prospective study.
Aubin-Pouliot A; Delagnes EA; Chang JL; Ryan WR
Laryngoscope; 2016 Jun; 126(6):1343-8. PubMed ID: 26972293
[TBL] [Abstract][Full Text] [Related]
18. Late side effects of radioactive iodine on salivary gland function in patients with thyroid cancer.
Almeida JP; Sanabria AE; Lima EN; Kowalski LP
Head Neck; 2011 May; 33(5):686-90. PubMed ID: 21484917
[TBL] [Abstract][Full Text] [Related]
19. Salivary gland protection by amifostine in high-dose radioiodine treatment: results of a double-blind placebo-controlled study.
Bohuslavizki KH; Klutmann S; Brenner W; Mester J; Henze E; Clausen M
J Clin Oncol; 1998 Nov; 16(11):3542-9. PubMed ID: 9817273
[TBL] [Abstract][Full Text] [Related]
20. Radioiodine-Induced Salivary Gland Damage Detected by Ultrasonography in Patients Treated for Papillary Thyroid Cancer: Radioactive Iodine Activity and Risk.
Horvath E; Skoknic V; Majlis S; Tala H; Silva C; Castillo E; Whittle C; Niedmann JP; González P
Thyroid; 2020 Nov; 30(11):1646-1655. PubMed ID: 32370663
[No Abstract] [Full Text] [Related]
[Next] [New Search]
